Rhumbline Advisers Angiodynamics Inc Transaction History

Rhumbline Advisers

  • $104 Billion
  • Q1 2025

A detailed history of Rhumbline Advisers transactions in Angiodynamics Inc stock. As of the latest transaction made, Rhumbline Advisers holds 58,827 shares of ANGO stock, worth $558,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,827
Previous 60,479 2.73%
Holding current value
$558,856
Previous $553,000 0.9%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 08, 2025
SELL
$8.37 - $12.94 $13,827 - $21,376
-1,652 Reduced 2.73%
58,827 $558,000
Q4 2024

Jan 30, 2025
BUY
$5.88 - $9.33 $6,003 - $9,525
1,021 Added 1.72%
60,479 $553,000
Q3 2024

Nov 12, 2024
SELL
$5.51 - $7.84 $15,488 - $22,038
-2,811 Reduced 4.51%
59,458 $462,000
Q2 2024

Aug 01, 2024
BUY
$5.65 - $7.03 $2,779 - $3,458
492 Added 0.8%
62,269 $376,000
Q1 2024

May 09, 2024
SELL
$5.27 - $8.03 $5,733 - $8,736
-1,088 Reduced 1.73%
61,777 $362,000
Q4 2023

Feb 08, 2024
SELL
$6.17 - $8.04 $4,732 - $6,166
-767 Reduced 1.21%
62,865 $492,000
Q3 2023

Nov 09, 2023
SELL
$7.02 - $10.32 $467,925 - $687,889
-66,656 Reduced 51.16%
63,632 $465,000
Q2 2023

Aug 08, 2023
BUY
$8.29 - $11.16 $28,409 - $38,245
3,427 Added 2.7%
130,288 $1.36 Million
Q1 2023

May 11, 2023
BUY
$9.1 - $15.48 $58,986 - $100,341
6,482 Added 5.38%
126,861 $1.31 Million
Q4 2022

Feb 14, 2023
BUY
$12.06 - $21.55 $90,474 - $161,668
7,502 Added 6.65%
120,379 $1.66 Million
Q3 2022

Nov 10, 2022
BUY
$19.54 - $24.3 $99,106 - $123,249
5,072 Added 4.7%
112,877 $2.31 Million
Q2 2022

Aug 11, 2022
BUY
$17.83 - $24.49 $49,157 - $67,518
2,757 Added 2.62%
107,805 $2.09 Million
Q1 2022

May 12, 2022
SELL
$20.46 - $29.16 $16,756 - $23,882
-819 Reduced 0.77%
105,048 $2.26 Million
Q4 2021

Feb 10, 2022
SELL
$24.35 - $30.97 $95,719 - $121,743
-3,931 Reduced 3.58%
105,867 $2.92 Million
Q3 2021

Nov 12, 2021
SELL
$23.36 - $29.2 $334,818 - $418,523
-14,333 Reduced 11.55%
109,798 $2.85 Million
Q2 2021

Aug 05, 2021
SELL
$22.39 - $28.07 $148,714 - $186,440
-6,642 Reduced 5.08%
124,131 $3.37 Million
Q1 2021

May 06, 2021
BUY
$15.44 - $23.4 $2,856 - $4,329
185 Added 0.14%
130,773 $3.06 Million
Q4 2020

Feb 10, 2021
BUY
$10.34 - $15.33 $137,005 - $203,122
13,250 Added 11.29%
130,588 $2 Million
Q3 2020

Nov 12, 2020
SELL
$8.26 - $12.74 $58,009 - $89,473
-7,023 Reduced 5.65%
117,338 $1.42 Million
Q2 2020

Aug 13, 2020
SELL
$9.05 - $12.01 $64,979 - $86,231
-7,180 Reduced 5.46%
124,361 $1.27 Million
Q1 2020

May 06, 2020
BUY
$8.33 - $16.9 $24,615 - $49,939
2,955 Added 2.3%
131,541 $1.37 Million
Q4 2019

Feb 05, 2020
BUY
$14.23 - $18.16 $102,555 - $130,879
7,207 Added 5.94%
128,586 $2.06 Million
Q3 2019

Oct 23, 2019
BUY
$17.78 - $21.89 $143,840 - $177,090
8,090 Added 7.14%
121,379 $2.24 Million
Q2 2019

Aug 14, 2019
BUY
$18.78 - $25.01 $59,157 - $78,781
3,150 Added 2.86%
113,289 $2.23 Million
Q1 2019

May 01, 2019
BUY
$19.43 - $23.46 $36,567 - $44,151
1,882 Added 1.74%
110,139 $2.52 Million
Q4 2018

Jan 31, 2019
BUY
$18.9 - $22.06 $396,484 - $462,774
20,978 Added 24.04%
108,257 $2.18 Million
Q3 2018

Nov 07, 2018
SELL
$18.95 - $24.23 $10,593 - $13,544
-559 Reduced 0.64%
87,279 $1.9 Million
Q2 2018

Aug 06, 2018
BUY
$17.42 - $23.0 $35,902 - $47,403
2,061 Added 2.4%
87,838 $1.95 Million
Q1 2018

May 02, 2018
BUY
$15.71 - $17.7 $16,762 - $18,885
1,067 Added 1.26%
85,777 $1.48 Million
Q4 2017

Feb 09, 2018
BUY
$16.56 - $17.8 $196,070 - $210,752
11,840 Added 16.25%
84,710 $1.41 Million
Q3 2017

Nov 06, 2017
BUY
$16.09 - $18.76 $1.17 Million - $1.37 Million
72,870
72,870 $1.25 Million

Others Institutions Holding ANGO

# of Institutions
143
Shares Held
34.4M
Call Options Held
273K
Put Options Held
23.9K
View Full List

About ANGIODYNAMICS INC

ANGO Quotes by TradingView
  • Ticker ANGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 39,107,800
  • Market Cap $372M
  • Description
  • AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...
More about ANGO
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email